• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunization by direct DNA inoculation induces rejection of tumor cell challenge.

作者信息

Wang B, Merva M, Dang K, Ugen K E, Williams W V, Weiner D B

机构信息

Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

出版信息

Hum Gene Ther. 1995 Apr;6(4):407-18. doi: 10.1089/hum.1995.6.4-407.

DOI:10.1089/hum.1995.6.4-407
PMID:7612698
Abstract

Direct DNA inoculation is the basis for a new technology that has been successfully used for in vivo induction of both humoral and cellular immune responses. However, the immunological parameters of this new approach remain to be evaluated in detail. We report here that direct DNA inoculation can induce protection from malignant tumor cell challenge through the generation of specific immune responses directed against antigens displayed on the tumor cells. The protected mice remain tumor-free for more than 1 year post-challenge. Memory responses upon tumor rechallenge were observed for both humoral and cellular immunity. Inoculated animals were able to reject otherwise lethal tumors several months following the original DNA inoculation protocol. These in vivo protective responses suggest that further analysis of this technology for vaccine development or immune therapeutic strategies is warranted.

摘要

相似文献

1
Immunization by direct DNA inoculation induces rejection of tumor cell challenge.
Hum Gene Ther. 1995 Apr;6(4):407-18. doi: 10.1089/hum.1995.6.4-407.
2
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.复制缺陷型腺病毒重组载体单次免疫诱导的长期体液免疫和细胞免疫。
Eur J Immunol. 1995 Dec;25(12):3467-73. doi: 10.1002/eji.1830251239.
3
DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells.DNA接种可诱导针对表达HIV-1抗原的细胞进行细胞攻击的体内保护性免疫反应。
AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S35-41.
4
A carcinoembryonic antigen polynucleotide vaccine for human clinical use.一种用于人类临床的癌胚抗原多核苷酸疫苗。
Cancer Gene Ther. 1995 Mar;2(1):33-8.
5
Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.基于信使 RNA 的具有双重活性的疫苗可诱导平衡的 TLR-7 依赖性适应性免疫应答,并具有抗肿瘤活性。
J Immunother. 2011 Jan;34(1):1-15. doi: 10.1097/CJI.0b013e3181f7dbe8.
6
Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tau.
Hum Antibodies Hybridomas. 1996;7(1):21-6.
7
Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.用编码小鼠TRP2的重组腺病毒对小鼠进行基于树突状细胞的基因免疫可诱导有效的抗黑色素瘤免疫。
J Gene Med. 1999 Nov-Dec;1(6):400-6. doi: 10.1002/(SICI)1521-2254(199911/12)1:6<400::AID-JGM68>3.0.CO;2-D.
8
[Specifics anti-tumor immunity induced by gene immunization with ectopic hCGbeta encoding gene].[异位表达人绒毛膜促性腺激素β编码基因的基因免疫诱导的特异性抗肿瘤免疫]
Zhonghua Zhong Liu Za Zhi. 2003 Jul;25(4):316-9.
9
Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.裸DNA免疫作为一种靶向通用肿瘤抗原生存素的方法,可在小鼠体内诱导体液免疫和细胞免疫反应。
Immunobiology. 2006;211(1-2):11-27. doi: 10.1016/j.imbio.2005.08.002. Epub 2005 Dec 27.
10
Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.抗原特异性肿瘤疫苗。编码MART1或gp100的重组腺病毒用于癌症治疗的研发与特性分析。
J Immunol. 1996 Jan 15;156(2):700-10.

引用本文的文献

1
Adjuvant effects of L. acidophilus LW1 on immune responses to the foot-and-mouth disease virus DNA vaccine in mice.嗜酸乳杆菌LW1对小鼠口蹄疫病毒DNA疫苗免疫反应的佐剂作用。
PLoS One. 2014 Aug 13;9(8):e104446. doi: 10.1371/journal.pone.0104446. eCollection 2014.
2
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.无法使用编码gp100黑色素瘤-黑素细胞抗原的质粒DNA对转移性黑色素瘤患者进行免疫接种。
Hum Gene Ther. 2003 May 20;14(8):709-14. doi: 10.1089/104303403765255110.
3
Cellular but not humoral immune responses generated by vaccination with dendritic cells protect mice against leukaemia.
用树突状细胞接种产生的细胞免疫而非体液免疫反应可保护小鼠免受白血病侵害。
Immunology. 2000 Jan;99(1):8-15. doi: 10.1046/j.1365-2567.2000.00933.x.
4
Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy.用不同细胞因子组合培养的小鼠骨髓来源树突状细胞的免疫表型和功能异质性:对肿瘤细胞治疗的意义
Immunology. 1999 Apr;96(4):569-77. doi: 10.1046/j.1365-2567.1999.00728.x.
5
Prospects for the therapeutic use of anticancer vaccines.抗癌疫苗的治疗应用前景。
Drugs. 1999 Mar;57(3):309-25. doi: 10.2165/00003495-199957030-00004.
6
Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.免疫疗法III:组合分子免疫疗法——综述与建议
Cancer Metastasis Rev. 1996 Sep;15(3):351-64. doi: 10.1007/BF00046347.
7
The next wave of recombinant and synthetic anticancer vaccines.下一代重组和合成抗癌疫苗。
Semin Cancer Biol. 1995 Dec;6(6):337-47. doi: 10.1016/1044-579x(95)90003-9.
8
New therapeutic approaches based on gene transfer techniques.基于基因转移技术的新治疗方法。
Springer Semin Immunopathol. 1996;18(2):149-70. doi: 10.1007/BF00820663.
9
Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1.针对黑色素瘤相关抗原(MAGE)的基因疫苗和细胞疫苗诱导抗原特异性肿瘤免疫:通过共表达粒细胞-巨噬细胞集落刺激因子(GM-CSF)和B7-1增强肿瘤保护作用
Mol Med. 1996 Sep;2(5):545-55.
10
Immunotherapeutic strategies targeting rheumatoid synovial T-cell receptors by DNA inoculation.通过DNA接种靶向类风湿性滑膜T细胞受体的免疫治疗策略。
Immunol Res. 1994;13(2-3):145-53. doi: 10.1007/BF02918275.